Detailed information for compound 461019

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 349.426 | Formula: C21H23N3O2
  • H donors: 1 H acceptors: 2 LogP: 3.18 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(c1cccc(c1C)C)N1CCC(CC1)n1c(=O)[nH]c2c1cccc2
  • InChi: 1S/C21H23N3O2/c1-14-6-5-7-17(15(14)2)20(25)23-12-10-16(11-13-23)24-19-9-4-3-8-18(19)22-21(24)26/h3-9,16H,10-13H2,1-2H3,(H,22,26)
  • InChiKey: PXRZEQLIIQBDGW-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens hydroxysteroid (11-beta) dehydrogenase 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Mycobacterium ulcerans short chain dehydrogenase Get druggable targets OG5_132866 All targets in OG5_132866
Mycobacterium tuberculosis Probable oxidoreductase Get druggable targets OG5_132866 All targets in OG5_132866

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum steroid dehydrogenase, putative hydroxysteroid (11-beta) dehydrogenase 1 292 aa 250 aa 24.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium tuberculosis Probable oxidoreductase 0.0338 0.0227 0.5
Trypanosoma brucei Aph-1 protein, putative 0.1994 0.3613 1
Echinococcus multilocularis gamma secretase subunit aph 1 0.5118 1 1
Echinococcus multilocularis presenilin 0.0649 0.0862 0.0693
Trypanosoma cruzi Aph-1 protein, putative 0.1994 0.3613 1
Echinococcus granulosus presenilin enhancer 2 0.0609 0.078 0.061
Trichomonas vaginalis Clan AD, family A22, presenilin-like aspartic peptidase 0.0649 0.0862 1
Schistosoma mansoni gamma-secretase subunit aph-1 0.5118 1 1
Brugia malayi hypothetical protein 0.0316 0.0182 0.0182
Loa Loa (eye worm) hypothetical protein 0.0316 0.0182 0.0182
Echinococcus granulosus gamma secretase subunit aph 1 0.5118 1 1
Entamoeba histolytica presenilin 1 peptidase, putative 0.0649 0.0862 0.5
Trichomonas vaginalis Clan AD, family A22, presenilin-like aspartic peptidase 0.0649 0.0862 1
Loa Loa (eye worm) gamma-secretase subunit pen-2 0.0609 0.078 0.078
Trichomonas vaginalis Clan AD, family A22, presenilin-like aspartic peptidase 0.0649 0.0862 1
Leishmania major presenilin-like aspartic peptidase, putative,presenilin-like aspartic peptidase, clan AD, family A22A, putative 0.0649 0.0862 0.5
Trypanosoma cruzi Aph-1 protein, putative 0.1994 0.3613 1
Mycobacterium ulcerans short chain dehydrogenase 0.0338 0.0227 0.5
Brugia malayi gamma-secretase subunit pen-2 0.0609 0.078 0.078
Schistosoma mansoni subfamily A22A unassigned peptidase (A22 family) 0.0649 0.0862 0.0693
Echinococcus multilocularis presenilin enhancer 2 0.0609 0.078 0.061
Brugia malayi hypothetical protein 0.0316 0.0182 0.0182
Brugia malayi Presenilin family protein 0.0649 0.0862 0.0862
Loa Loa (eye worm) gamma-secretase subunit aph-1 0.5118 1 1
Toxoplasma gondii hypothetical protein 0.0227 0 0.5
Echinococcus granulosus presenilin 0.0649 0.0862 0.0693

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 1.1 uM Inhibition of human 11betaHSD1 by SPA ChEMBL. 17442567
Ki (binding) = 1.1 uM Inhibition of human 11betaHSD1 by SPA ChEMBL. 17442567

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.